| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |